Stock CRNX CRINETICS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Crinetics Pharmaceuticals, Inc.

Equities

CRNX

US22663K1079

Real-time Estimate Cboe BZX
Other stock markets
 09:16:12 14/05/2024 pm IST 		5-day change 1st Jan Change
48.88 USD +1.98% Intraday chart for Crinetics Pharmaceuticals, Inc. +2.58% +37.41%
10/05 Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing MT
09/05 Crinetics Pharmaceuticals Q1 Net Loss Widens MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing
MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $639,256, According to a Recent SEC Filing
MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $1,433,675, According to a Recent SEC Filing
MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $664,763, According to a Recent SEC Filing
MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $2,648,150, According to a Recent SEC Filing
MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $449,793, According to a Recent SEC Filing
MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $354,700, According to a Recent SEC Filing
MT
Crinetics Pharmaceuticals CEO Sold Shares Worth $6,111,440, According to a Recent SEC Filing
MT
Crinetics Pharmaceuticals Insider Sold Shares Worth $210,000, According to a Recent SEC Filing
MT
Insider Sell: Crinetics Pharmaceuticals
MT
Insider Sell: Crinetics Pharmaceuticals
MT
Insider Sell: Crinetics Pharmaceuticals
MT
Insider Buy: Crinetics Pharmaceuticals
MT
Insider Sell: Crinetics Pharmaceuticals
MT
Crinetics Pharmaceuticals Appoints Dana Pizzuti as Chief Development Officer
CI
Insider Sell: Crinetics Pharmaceuticals
MT
Insider Sell: Crinetics Pharmaceuticals
MT
Insider Sell: Crinetics Pharmaceuticals
MT
Crinetics Pharmaceuticals, Inc. Announces Resignation of Ajay Madan as Chief Development Officer, Effective April 1, 2022
CI
Crinetics Pharmaceuticals, Inc. Appoints Chris Robillard as Chief Business Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRNX Stock
  4. News Crinetics Pharmaceuticals, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW